イソトレチノイン医薬品の世界市場レポート 2025年

イソトレチノイン医薬品市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR5.5％で16億9,000万米ドルに成長します。予測期間の成長は、認知度の高まりとスキンケア動向、新興市場での拡大、ニキビの発生率の増加、人口の高齢化、メンタルヘルスとウェルビーイングの重視に起因すると考えられます。予測期間における主な動向としては、研究開発、技術の進歩、ジェネリック医薬品の革新、製剤の改良、皮膚科学の進歩などが挙げられます。

皮膚がん患者の増加は、今後のイソトレチノイン医薬品市場の拡大を牽引すると予想されます。皮膚がんは、異常な皮膚細胞が制御不能に増殖することで発生し、多くの場合、太陽や日焼けベッドからの紫外線（UV）に長時間さらされることで引き起こされます。皮膚がんの罹患率の増加は、紫外線への暴露の増加、オゾン層の破壊、十分な日焼け対策をせずに屋外で活動するライフスタイルの変化に起因しています。イソトレチノイン医薬品は、異常な皮膚細胞の増殖を抑えることによって、ある種の皮膚がんを予防・治療するために使用されます。例えば、米国がん協会は、2024年1月に報告される皮膚がんの症例数は108,270例で、2023年に報告された104,930例から3.2％増加すると予測しています。したがって、皮膚がんの有病率の上昇は、イソトレチノイン医薬品市場を後押しすることになります。

イソトレチノイン製剤市場の主要企業は、治療の選択肢を増やし患者の利用しやすさを広げるため、イソトレチノインカプセルのような高度な製剤の開発に注力しています。これらのカプセルは通常、結節性ニキビや嚢胞性ニキビなどの重度のニキビ症状に処方され、重大な副作用、特に先天性異常のリスクが高いため、厳格な使用ガイドラインが定められています。例えば、2023年7月、米国に本社を置く製薬会社Upsher-Smith Laboratories, LLCは、最初のイソトレチノインカプセルUSPを発売しました。10mg、20mg、30mg、40mgの用量で入手可能なこのカプセルは、アキュテインと治療上同等（TEコードAB1）です。この薬は重度のにきび治療に推奨され、困難な症例に確実な解決策を提供します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界イソトレチノイン医薬品 PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のイソトレチノイン医薬品市場：成長率分析
• 世界のイソトレチノイン医薬品市場の実績：規模と成長, 2019-2024
• 世界のイソトレチノイン医薬品市場の予測：規模と成長, 2024-2029, 2034F
• 世界イソトレチノイン医薬品総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のイソトレチノイン医薬品市場：形態別、実績と予測, 2019-2024, 2024-2029F, 2034F
• カプセル
• 注射
• 世界のイソトレチノイン医薬品市場適応症別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 重度のニキビ
• 神経芽細胞腫
• 皮膚T細胞リンパ腫
• ハーレクイン魚鱗癬
• 色素性乾皮症
• 進行性骨化性線維異形成症
• 扁平上皮細胞皮膚がん
• その他の適応症の種類
• 世界のイソトレチノイン医薬品市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院薬局
• 小売薬局
• オンライン薬局
• 世界のイソトレチノイン医薬品市場カプセルの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ソフトジェルカプセル
• ハードジェルカプセル
• 液体入りカプセル
• 世界のイソトレチノイン医薬品市場、注射のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 静脈注射
• 筋肉内注射

第7章 地域別・国別分析

• 世界のイソトレチノイン医薬品市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のイソトレチノイン医薬品市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• イソトレチノイン医薬品市場：競合情勢
• イソトレチノイン医薬品市場：企業プロファイル
  • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Viatris Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Bausch Health Companies Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Hetero Drugs Ltd.
• Sun Pharmaceuticals Industries Limited
• Intas Pharmaceuticals Ltd.
• Aurobindo Pharma
• Dr. Reddy's Laboratories Ltd.
• Cipla Limited
• Amneal Pharmaceuticals LLC
• Lupin Pharmaceuticals Inc.
• Zydus Lifesciences Limited
• Glenmark Pharmaceuticals
• Alkem Laboratories
• Torrent Pharmaceuticals Ltd
• Almirall LLC
• Alembic Pharmaceuticals Ltd
• Ajanta Pharma Ltd.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• イソトレチノイン医薬品市場2029：新たな機会を提供する国
• イソトレチノイン医薬品市場2029：新たな機会を提供するセグメント
• イソトレチノイン医薬品市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Isotretinoin is a potent medication derived from vitamin A, primarily used to treat severe acne, often leading to significant improvement in skin conditions. It works by reducing oil production and promoting skin renewal, resulting in clearer and healthier skin for many individuals. Typically prescribed when other treatments have failed, it requires strict medical supervision and careful consideration of potential risks and benefits.

The main types of isotretinoin drugs include capsules and injections. Isotretinoin capsules are oral medications that reduce natural oil production in the skin, prevent clogged pores, and help treat and prevent acne. These drugs are indicated for conditions such as severe acne, neuroblastoma, cutaneous T-cell lymphoma, harlequin ichthyosis, Xeroderma pigmentosum, fibrodysplasia ossificans progressiva, squamous cell skin cancers, and others. They are distributed through channels such as hospital pharmacies, retail pharmacies, and online pharmacies.

The isotretinoin drugs market research report is one of a series of new reports from the business research company that provides isotretinoin drugs market statistics, including isotretinoin drugs industry global market size, regional shares, competitors with an isotretinoin drugs market share, detailed isotretinoin drugs market segments, market trends and opportunities, and any further data you may need to thrive in the isotretinoin drugs industry. This isotretinoin drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The isotretinoin drugs market size has grown strongly in recent years. It will grow from $1.29 billion in 2024 to $1.36 billion in 2025 at a compound annual growth rate (CAGR) of 5.8%. The growth in the historic period can be attributed to the prevalence of severe acne, the effectiveness of isotretinoin, marketing and awareness campaigns, regulatory approvals, and increased dermatology visits.

The isotretinoin drugs market size is expected to see strong growth in the next few years. It will grow to $1.69 billion in 2029 at a compound annual growth rate (CAGR) of 5.5%. The growth in the forecast period can be attributed to growing awareness and skincare trends, expansion in emerging markets, increasing incidence of acne, aging population, and focus on mental health and well-being. Major trends in the forecast period include research and development, technological advancements, generic drug innovations, improved formulations, and advances in dermatology.

The growth in skin cancer cases is expected to drive the expansion of the isotretinoin drugs market in the future. Skin cancer results from the uncontrolled growth of abnormal skin cells, often caused by prolonged exposure to ultraviolet (UV) radiation from the sun or tanning beds. The increasing incidence of skin cancer can be attributed to greater UV radiation exposure, depletion of the ozone layer, and lifestyle changes leading to more outdoor activities without sufficient sun protection. Isotretinoin drugs are used to prevent and treat certain types of skin cancer by reducing the proliferation of abnormal skin cells. For example, the American Cancer Society projects that there will be 108,270 reported cases of skin cancer in January 2024, representing a 3.2% increase from the 104,930 cases reported in 2023. Hence, the rising prevalence of skin cancer is set to boost the isotretinoin drugs market.

Major players in the isotretinoin drug market are focusing on developing advanced formulations, such as isotretinoin capsules, to improve treatment options and broaden patient accessibility. These capsules are typically prescribed for severe acne conditions, such as nodular or cystic acne, and come with strict usage guidelines due to their significant side effects, especially the high risk of birth defects. For example, in July 2023, Upsher-Smith Laboratories, LLC, a pharmaceutical company based in the US, introduced the first Isotretinoin Capsules USP. Available in 10 mg, 20 mg, 30 mg, and 40 mg doses, these capsules are therapeutically equivalent (TE code AB1) to the brand Accutane. This medication is recommended for treating severe acne, providing a reliable solution for challenging cases.

In January 2024, CHEPLAPHARM Arzneimittel GmbH, a Germany-based pharmaceutical company, acquired Roaccutane from F. Hoffmann-La Roche Ltd. for an undisclosed sum. This acquisition bolsters CHEPLAPHARM Group's dermatological portfolio by securing global rights to Roaccutane, a well-established retinoid medication used to treat severe acne and as a therapeutic option worldwide. F. Hoffmann-La Roche Ltd. is a Switzerland-based healthcare company that manufactures isotretinoin drugs such as Roaccutane.

Major companies operating in the isotretinoin drugs market are F. Hoffmann-La Roche Ltd., Abbott Laboratories, Viatris Inc., Teva Pharmaceutical Industries Ltd., Bausch Health Companies Inc., Hetero Drugs Ltd., Sun Pharmaceuticals Industries Limited, Intas Pharmaceuticals Ltd., Aurobindo Pharma, Dr. Reddy's Laboratories Ltd., Cipla Limited, Amneal Pharmaceuticals LLC, Lupin Pharmaceuticals Inc, Zydus Lifesciences Limited, Glenmark Pharmaceuticals, Alkem Laboratories, Torrent Pharmaceuticals Ltd, Almirall LLC, Alembic Pharmaceuticals Ltd, Ajanta Pharma Ltd, Strides Pharma Science Limited, Wockhardt Ltd., Douglas Pharmaceuticals Limited, Chongqing Huapont Pharm Co. Ltd., Cipher Pharmaceuticals Inc., Vidhyasha Pharmaceuticals

North America was the largest region in the isotretinoin drugs market in 2024. The regions covered in the isotretinoin drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the isotretinoin drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The isotretinoin drugs market consists of sales of softgels, tablets, and ointments. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Isotretinoin Drugs Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on isotretinoin drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for isotretinoin drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The isotretinoin drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Form: Capsules; Injection
• 2) By Indication Type: Severe Acne; Neuroblastoma; Cutaneous T-Cell Lymphoma; Harlequin Ichthyosis; Xeroderma Pigmentosum; Fibrodysplasia Ossificans Progressiva; Squamous Cell Skin Cancers; Other Indication Types
• 3) By Distribution Channel: Hospitals Pharmacies; Retail Pharmacies; Online Pharmacies
• Subsegments:
• 1) By Capsules: Soft Gel Capsules; Hard Gel Capsules; Liquid-Filled Capsules
• 2) By Injection: Intravenous Injection; Intramuscular Injection
• Companies Mentioned: F. Hoffmann-La Roche Ltd.; Abbott Laboratories; Viatris Inc.; Teva Pharmaceutical Industries Ltd.; Bausch Health Companies Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Isotretinoin Drugs Market Characteristics

3. Isotretinoin Drugs Market Trends And Strategies

4. Isotretinoin Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Isotretinoin Drugs Growth Analysis And Strategic Analysis Framework

• 5.1. Global Isotretinoin Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Isotretinoin Drugs Market Growth Rate Analysis
• 5.4. Global Isotretinoin Drugs Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Isotretinoin Drugs Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Isotretinoin Drugs Total Addressable Market (TAM)

6. Isotretinoin Drugs Market Segmentation

• 6.1. Global Isotretinoin Drugs Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Capsules
• Injection
• 6.2. Global Isotretinoin Drugs Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Severe Acne
• Neuroblastoma
• Cutaneous T-Cell Lymphoma
• Harlequin Ichthyosis
• Xeroderma Pigmentosum
• Fibrodysplasia Ossificans Progressiva
• Squamous Cell Skin Cancers
• Other Indication Types
• 6.3. Global Isotretinoin Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals Pharmacies
• Retail Pharmacies
• Online Pharmacies
• 6.4. Global Isotretinoin Drugs Market, Sub-Segmentation Of Capsules, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Soft Gel Capsules
• Hard Gel Capsules
• Liquid-Filled Capsules
• 6.5. Global Isotretinoin Drugs Market, Sub-Segmentation Of Injection, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Intravenous Injection
• Intramuscular Injection

7. Isotretinoin Drugs Market Regional And Country Analysis

• 7.1. Global Isotretinoin Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Isotretinoin Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Isotretinoin Drugs Market

• 8.1. Asia-Pacific Isotretinoin Drugs Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Isotretinoin Drugs Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Isotretinoin Drugs Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Isotretinoin Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Isotretinoin Drugs Market

• 9.1. China Isotretinoin Drugs Market Overview
• 9.2. China Isotretinoin Drugs Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Isotretinoin Drugs Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Isotretinoin Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Isotretinoin Drugs Market

• 10.1. India Isotretinoin Drugs Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Isotretinoin Drugs Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Isotretinoin Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Isotretinoin Drugs Market

• 11.1. Japan Isotretinoin Drugs Market Overview
• 11.2. Japan Isotretinoin Drugs Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Isotretinoin Drugs Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Isotretinoin Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Isotretinoin Drugs Market

• 12.1. Australia Isotretinoin Drugs Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Isotretinoin Drugs Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Isotretinoin Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Isotretinoin Drugs Market

• 13.1. Indonesia Isotretinoin Drugs Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Isotretinoin Drugs Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Isotretinoin Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Isotretinoin Drugs Market

• 14.1. South Korea Isotretinoin Drugs Market Overview
• 14.2. South Korea Isotretinoin Drugs Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Isotretinoin Drugs Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Isotretinoin Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Isotretinoin Drugs Market

• 15.1. Western Europe Isotretinoin Drugs Market Overview
• 15.2. Western Europe Isotretinoin Drugs Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Isotretinoin Drugs Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Isotretinoin Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Isotretinoin Drugs Market

• 16.1. UK Isotretinoin Drugs Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Isotretinoin Drugs Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Isotretinoin Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Isotretinoin Drugs Market

• 17.1. Germany Isotretinoin Drugs Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Isotretinoin Drugs Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Isotretinoin Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Isotretinoin Drugs Market

• 18.1. France Isotretinoin Drugs Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Isotretinoin Drugs Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Isotretinoin Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Isotretinoin Drugs Market

• 19.1. Italy Isotretinoin Drugs Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Isotretinoin Drugs Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Isotretinoin Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Isotretinoin Drugs Market

• 20.1. Spain Isotretinoin Drugs Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Isotretinoin Drugs Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Isotretinoin Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Isotretinoin Drugs Market

• 21.1. Eastern Europe Isotretinoin Drugs Market Overview
• 21.2. Eastern Europe Isotretinoin Drugs Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Isotretinoin Drugs Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Isotretinoin Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Isotretinoin Drugs Market

• 22.1. Russia Isotretinoin Drugs Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Isotretinoin Drugs Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Isotretinoin Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Isotretinoin Drugs Market

• 23.1. North America Isotretinoin Drugs Market Overview
• 23.2. North America Isotretinoin Drugs Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Isotretinoin Drugs Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Isotretinoin Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Isotretinoin Drugs Market

• 24.1. USA Isotretinoin Drugs Market Overview
• 24.2. USA Isotretinoin Drugs Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Isotretinoin Drugs Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Isotretinoin Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Isotretinoin Drugs Market

• 25.1. Canada Isotretinoin Drugs Market Overview
• 25.2. Canada Isotretinoin Drugs Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Isotretinoin Drugs Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Isotretinoin Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Isotretinoin Drugs Market

• 26.1. South America Isotretinoin Drugs Market Overview
• 26.2. South America Isotretinoin Drugs Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Isotretinoin Drugs Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Isotretinoin Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Isotretinoin Drugs Market

• 27.1. Brazil Isotretinoin Drugs Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Isotretinoin Drugs Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Isotretinoin Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Isotretinoin Drugs Market

• 28.1. Middle East Isotretinoin Drugs Market Overview
• 28.2. Middle East Isotretinoin Drugs Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Isotretinoin Drugs Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Isotretinoin Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Isotretinoin Drugs Market

• 29.1. Africa Isotretinoin Drugs Market Overview
• 29.2. Africa Isotretinoin Drugs Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Isotretinoin Drugs Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Isotretinoin Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Isotretinoin Drugs Market Competitive Landscape And Company Profiles

• 30.1. Isotretinoin Drugs Market Competitive Landscape
• 30.2. Isotretinoin Drugs Market Company Profiles
  • 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Viatris Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Bausch Health Companies Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Isotretinoin Drugs Market Other Major And Innovative Companies

• 31.1. Hetero Drugs Ltd.
• 31.2. Sun Pharmaceuticals Industries Limited
• 31.3. Intas Pharmaceuticals Ltd.
• 31.4. Aurobindo Pharma
• 31.5. Dr. Reddy's Laboratories Ltd.
• 31.6. Cipla Limited
• 31.7. Amneal Pharmaceuticals LLC
• 31.8. Lupin Pharmaceuticals Inc.
• 31.9. Zydus Lifesciences Limited
• 31.10. Glenmark Pharmaceuticals
• 31.11. Alkem Laboratories
• 31.12. Torrent Pharmaceuticals Ltd
• 31.13. Almirall LLC
• 31.14. Alembic Pharmaceuticals Ltd
• 31.15. Ajanta Pharma Ltd.

32. Global Isotretinoin Drugs Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Isotretinoin Drugs Market

34. Recent Developments In The Isotretinoin Drugs Market

35. Isotretinoin Drugs Market High Potential Countries, Segments and Strategies

• 35.1 Isotretinoin Drugs Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Isotretinoin Drugs Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Isotretinoin Drugs Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer